Related Experiment Video

Updated: Jul 11, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis

Elena Ambrosino1, Masaki Terabe, Ramesh C Halder

  • 1National Cancer Institute, Bethesda, MD 20892, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|October 4, 2007
PubMed

Insights

Natural killer T (NKT) cells regulate tumor immunity. Type I NKT cells protect against tumors, while type II NKT cells suppress immunity, with potential therapeutic implications.

Area of Science:

  • Immunology
  • Cancer Biology
  • Immunotherapy

Background:

  • Negative immunoregulation hinders cancer immunotherapy efficacy.
  • Natural Killer T (NKT) cells are key immune regulators.
  • Understanding NKT cell subsets is crucial for cancer treatment.

Purpose of the Study:

  • To investigate the distinct and interactive roles of type I and type II NKT cells in tumor immunity.
  • To elucidate the immunoregulatory axis formed by these NKT cell types.

Main Methods:

  • Selective stimulation of type I and type II NKT cells.
  • In vitro and in vivo experiments assessing immune responses and tumor growth.
  • Analysis of cytokine profiles (e.g., Th2).

Main Results:

  • Selective type II NKT cell stimulation suppressed anti-tumor immunosurveillance.
  • Type I NKT cell stimulation provided protection against tumor growth.
  • Simultaneous stimulation showed type II NKT cells suppressing type I NKT cell functions.
  • Type I NKT cells were found to mitigate the suppressive effects of type II NKT cells.

Conclusions:

  • Type I and type II NKT cells exert opposing and counteractive roles in tumor immunity, establishing a novel immunoregulatory axis.
  • Modulating the balance between protective type I and suppressive type II NKT cells offers a potential strategy for cancer therapeutic intervention.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...